Medical Education Library

Counseling our patients regarding cycle control

Sponsored by and content developed in conjunction with Ortho Women's Health and Urology, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Author and Disclosure Information

Highlights from a randomized clinical trial comparing a 21-day and a 24-day oral contraceptive regimen


 

Unscheduled bleeding (ie, spotting/breakthrough bleeding) and early, late, or absent withdrawal bleeding are common reasons cited by women for discontinuing use of oral contraceptives (OCs).3-5 A European survey of nearly 7000 current or past users of OCs found that women who experienced side effects such as unscheduled bleeding in the first 3 months of use were nearly twice as likely to discontinue use as those who reported no cycle control problems during this time.4

Next Article: